These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15074002)

  • 1. DKK1 in multiple myeloma.
    Hofbauer LC; Neubauer A; Schoppet M
    N Engl J Med; 2004 Apr; 350(14):1464-6; author reply 1464-6. PubMed ID: 15074002
    [No Abstract]   [Full Text] [Related]  

  • 2. DKK1 in multiple myeloma.
    Lu CM
    N Engl J Med; 2004 Apr; 350(14):1464-6; author reply 1464-6. PubMed ID: 15074001
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of receptor activator of nuclear factor-kB ligand (RANKL) expression and functional production by human multiple myeloma cells.
    Giuliani N; Colla S; Morandi F; Barille-Nion S; Rizzoli V
    Haematologica; 2005 Feb; 90(2):275-8. PubMed ID: 15710592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and clinical relevance of receptor activator of nuclear factor kappaB ligand expression of myeloma cells.
    Heider U; Zavrski I; Jakob C; Fleissner C; Sezer O
    Cancer Res; 2004 Jan; 64(2):773-4; author reply 774-5. PubMed ID: 14744798
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple myeloma.
    Schneider HG; Sentry J
    N Engl J Med; 2005 Feb; 352(8):840-1; author reply 840-1. PubMed ID: 15736296
    [No Abstract]   [Full Text] [Related]  

  • 6. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.
    Giuliani N; Colla S; Morandi F; Rizzoli V
    Haematologica; 2004 Sep; 89(9):1118-23. PubMed ID: 15377473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do human myeloma cells directly produce the receptor activator of nuclear factor kappaB ligand (RANKL) or induce RANKL in the bone marrow microenvironment?
    Giuliani N; Colla S; Rizzoli V; Barillé-Nion S; Bataille R
    Cancer Res; 2004 Jan; 64(2):772-3; author reply 774-5. PubMed ID: 14744797
    [No Abstract]   [Full Text] [Related]  

  • 8. DKK1 in multiple myeloma.
    Meyer MA
    N Engl J Med; 2004 Apr; 350(14):1464-6; author reply 1464-6. PubMed ID: 15070800
    [No Abstract]   [Full Text] [Related]  

  • 9. Evolution of understanding of genetics of Paget's disease of bone and related diseases.
    Takata S; Yasui N; Nakatsuka K; Ralston SH
    J Bone Miner Metab; 2004; 22(6):519-23. PubMed ID: 15490260
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2.
    Nadiminty N; Lou W; Lee SO; Mehraein-Ghomi F; Kirk JS; Conroy JM; Zhang H; Gao AC
    Clin Cancer Res; 2006 Mar; 12(5):1420-30. PubMed ID: 16533764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone lesions in molecular subtypes of multiple myeloma.
    Robbiani DF; Chesi M; Bergsagel PL
    N Engl J Med; 2004 Jul; 351(2):197-8. PubMed ID: 15247367
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma.
    Tian E; Zhan F; Walker R; Rasmussen E; Ma Y; Barlogie B; Shaughnessy JD
    N Engl J Med; 2003 Dec; 349(26):2483-94. PubMed ID: 14695408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating rapid responses to 1,25-dihydroxyvitamin D3 with transcriptional changes in osteoblasts: Ca2+ regulated pathways to the nucleus.
    Farach-Carson MC; Bergh JJ; Xu Y
    Steroids; 2004 Aug; 69(8-9):543-7. PubMed ID: 15288767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells.
    Secchiero P; Corallini F; Barbarotto E; Melloni E; di Iasio MG; Tiribelli M; Zauli G
    J Cell Physiol; 2006 Apr; 207(1):158-64. PubMed ID: 16270354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor kappa B ligand gene in osteoblasts and bone marrow stromal cells.
    Liu J; Yang H; Liu W; Cao X; Feng X
    J Cell Biochem; 2005 Nov; 96(4):716-27. PubMed ID: 16052479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the pathogenesis of osteolysis in multiple myeloma patients.
    Giuliani N; Colla S; Rizzoli V
    Acta Biomed; 2004 Dec; 75(3):143-52. PubMed ID: 15796087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppresses osteoclast formation.
    Nguyen AN; Stebbins EG; Henson M; O'Young G; Choi SJ; Quon D; Damm D; Reddy M; Ma JY; Haghnazari E; Kapoun AM; Medicherla S; Protter A; Schreiner GF; Kurihara N; Anderson J; Roodman GD; Navas TA; Higgins LS
    Exp Cell Res; 2006 Jun; 312(10):1909-23. PubMed ID: 16600214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluid flow induces Rankl expression in primary murine calvarial osteoblasts.
    Mehrotra M; Saegusa M; Wadhwa S; Voznesensky O; Peterson D; Pilbeam C
    J Cell Biochem; 2006 Aug; 98(5):1271-83. PubMed ID: 16514640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RANK, RANKL and OPG in inflammatory arthritis and periprosthetic osteolysis.
    Ritchlin CT; Schwarz EM; O'Keefe RJ; Looney RJ
    J Musculoskelet Neuronal Interact; 2004 Sep; 4(3):276-84. PubMed ID: 15615495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional osteoclast-like transformation of cultured human myeloma cell lines.
    Calvani N; Cafforio P; Silvestris F; Dammacco F
    Br J Haematol; 2005 Sep; 130(6):926-38. PubMed ID: 16156862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.